SUMMARY Fibronectin is a glycoprotein secreted by connective tissue cells into their environment and into the blood. Plasma fibronectin has been isolated and used to prepare an antiserum. This has been shown to be specific for fibronectin and unreactive with fibrin(ogen) and collagen, to which fibronectin binds in vitro. The antiserum has been used to examine the distribution of this protein in the synovium in health, in rheumatoid arthritis, and in ostecarthrcsis, and to estimate levels in plasma and synovial fluid. The results suggest that fibronectin is synthesised by synovial cells, and the synovial fluid level of fibronectin was found to be about twice the plasma level in rheumatoid arthritis. In long-standing arthritis fibronectin was also found to be codistributed with (presumably by adsorption upon) fibrin and immature collagen in intra-articular structures but was no longer demonstrable in areas where mature collagen had been formed in areas undergoing fibrosis. The possible significance of local fibronectin production within joints in relation to its possible effect on the resolution or continuance of arthritis is discussed.
Fibronectin is a glycoprotein synthesised by connective tissue cells and secreted into their environment. It is also present in plasma and extracellular fluids. In plasma it binds to and coprecipitates with fibrinogen and fibrin in the cold and hence was originally designated as 'cold insoluble globulin" but has since been given other synonyms.2 Fibronectin also binds to collagen or gelatin, and this property has been utilised as a means of isolating it from plasma or from the medium in which cells are grown in tissue culture. 3 Comparison of the antisera elicited by immunising animals with fibronectin from these different sources suggests that cell-surface fibronectin is closely related antigenically to, and possibly may be the precursor of, plasma fibronectin. 4 Because fibronectin is a secretory product of connective tissue cells, and because of its mode of interaction with certain components (fibrin, collagen, glycosaminoglycans) concerned in the organisation and repair of damaged or inflamed tissues, it seemed important to investigate the possible role of fibronectin in rheumatic diseases. This is an account of an investigation of fibronectin concentration in plasma and synovial fluid and of its distribution in synovial tissue by immunochemical and immunohistological methods in health and in rheumatoid disease (RA) and osteoarthrosis (OA).
Materials and methods

COLLECTION OF SPECIMENS
Operative synovial biopsies were obtained from patients undergoing hip replacements or other joint surgery for RA or OA. Control biopsies were obtained from subjects with noninflammatory conditions necessitating operation (mainly meniscectomies). The 8 patients with RA from whom biopsies were obtained all had classical or definite disease according to the criteria ofthe American Rheumatism Association.5 Of the 8 patients with OA similarly yielding biopsy material 7 had polyarticular disease but not all had generalised OA with Heberden's nodes. Details of these patients and the controls are given in Table 1 . The biopsies from these patients were snap-frozen by immersion in liquid nitrogen and were stored at -800C until processed as described below. 9(6-13)
Hip (5) Knee (2) MCP* (1) *MCP = Metacarpophalangeal. Synovial fluid and plasma samples were collected from the patients detailed in Table 2 . The samples were collected aseptically into tubes containing ethylene diamine tetracetic acid (EDTA), spun to remove any cellular deposit, and stored at -200C until analysed. In addition, specimens of 'ricebodies' aspirated from the joints of 12 individuals were selected as specified in the 'Results' section from a large number of such specimens derived from a series of 45 patients with chronic synovial effusions associated with RA or OA.6 These specimens were examined as detailed below.
PREPARATION OF ANTIFIBRONECTIN ANTISERUM
Human fibronectin was isolated from plasma or the cryoprecipitate (antihaemophilic-factor-containing) fraction of plasma by affinity chromatography using gelatin coupled to cyanogen bromide treated Sepharose 4B (Pharmacia Ltd) according to the method of Engvall and Ruoslahti3 as modified by Dessau et al. 7 The fibronectin was further purified by the removal of minor contaminating plasma proteins by chromatography on a Sephacryl S300 (Pharmacia Ltd) column and elution with a buffer containing I M KBr in 0 05 M tris(hydroxymethyl) aminomethane and 0-1 M sodium chloride adjusted with 0-1 N HC1 to pH 7-6. The purity of the final product was assessed by sodium dodecyl sulphate polyacrylamide gel electrophoresis and by 1-and 2-dimensional immunoelectrophoresis using antiserum to whole human serum (Burroughs Wellcome Ltd).
The purified fibronectin was homogenised in They were examined as monolayers grown on the surface of glass cover slips immersed in these media for varying periods of time.
EXPERIMENTAL
The distinction between fibronectin and other connective tissue components. Fibronectin is know to bind to fibrinogen precipitated from plasma by heparin and other charged polysaccharides22; to fibrin during blood clotting23; or to collagen and its derivatives.324 It was necessary, therefore, before seeking to delineate the distribution of fibronectin in synovial fluids or synovial membranes to ensure that the antiserum to be used was truly specific for this glycoprotein and unreactive with other connective tissue components.
Distinction from fibrinogen or fibrin. It can be seen from Fig. 1 that when immunoelectrophoresis was carried out against normal plasma and normal serum, using antiserum to FRA and to fibronectin respectively, the following features could be observed: (i) the antiserum to FRA reacted, as expected, with plasma but not with serum, since fibrinogen is completely removed when plasma coagulates; (ii) on the other hand the antiserum to fibronectin reacted with both plasma and with serum, presumably because only a part of the fibronectin in plasma is adsorbed on the fibrin clot leaving a sufficient residue in serum to react with the antibody; (iii) the precipitin arcs given by fibrinogen and by fibronectin differed in shape, in position (i.e., in electrophoretic mobility), and crossed over one another to give 'a reaction of immunological nonidentity'. A similar reaction of nonidentity was obtained when each antiserum was tested against the same plasma sample by simple immunodiffusion (not shown).
It was concluded that the antifibronectin antiserum reacted with antigenic component(s) distinct from those present in fibrinogen. Since fibrin is immunologically almost indistinguishable from fibrinogen, it seemed reasonable to assume that fibronectin is also dissimilar to fibrin. These conclusions were of significance when the distribution of fibrin or fibrinogen and that of fibronectin werẽ~~~~~~~~~~. Relation between collagen and fibronectin. The binding affinity of fibronectin for collagen and its derivatives was confirmed by the successful use of the technique described for fibronectin isolation from plasma (adsorption on to a gelatin-Sepharose column-see 'Methods'). In order to examine the time relation of production of these 2 proteins by a mesenchymal cell known to synthesise both, fluorescein-or peroxidase-labelled antifibronectin was used to examine cultures of human skin fibroblasts grown as monolayers for varying periods of time. The appearances seen varied with the duration of growth and culture of the cells.
In primary cultures composed of individual randomly disposed fibroblasts treatment with labelled antiserum produced a granular but diffuse cytoplasmic staining, while the nucleus failed to stain (Fig. 2) . Little or no material reacting with the antiserum was seen extracellularly at this stage.
In older primary cultures composed of larger cell numbers, while apparent cytoplasmic staining was still a feature, it could be inferred that this appearance might also be due in part to surface membrane staining, since a fine fibrillar pattern could now be discerned overlying the negatively reacting nucleus in many cells. This surface staining was also in continuity with extended cell processes and with an irregular extracellular meshwork of fine fibrils which were strongly immunoreactive (Fig. 3) .
In primary cultures approaching confluence a much denser extracellular network of fibrils reacted with the antiserum and largely obscured the underlying fibroblasts (Fig. 4) . The cells at this stage were, in fact, difficult to descry in antiserum-treated preparations. This was not only because of the intensely staining overlying fibrillar network of extracellular fibronectin, but also because the cells themselves appeared to have lost much of their earlier reactivity with the antiserum. However, the cells could easily be demonstrated to be viable (by dye exclusion) and to be present in large numbers.
In cultures subjected to repeated passage, on the other hand, treatment with labelled antifibronectin demonstrated only extracellular fibrillary staining at all stages, from the initial adherence of single cells to the substratum to the formation of confluent It appeared from these observations that fibronectin is indeed an intrinsic secretory product of human fibroblasts but one that is distinct from, and which precedes the production of, mature collagen, the later major product of these cells. The results obtained are summarised in Table 2. propria of villus and around blood vessels. x 1000.
synovial cells there was evidence of specific fluorescence for fibronectin in the cytoplasm (but not the nucleus) of these cells and in a diffuse pericellular distribution (Fig. 5) . A fine network of fluorescence was also visible in the lamina propria, round the smooth muscle cells in the wall of small blood vessels, and along the basement membranes of these vessels ( Fig. 6A and B In the pathological biopsies an additional feature was seen which was absent from control biopsies. This was the occurrence of areas of intense fluorescence for fibronectin presenting as deposits of irregular shape and size, often enclosing cells reacting negatively. These deposits were frequently present on the surface of villi (Fig. 7B ) but in some instances appeared to have become incorporated into the superficial lining of villi. On examining corresponding sections from the same specimens with antifibrinogen, the areas reactive for fibronectin we found equally intense reactivity for FRA (Fig. 7A ).
In biopsies from subjects with long-standing chronic arthritis (both RA and OA) roughly spherical microscopic nodules were sometimes seen within the hypertrophied superficial lining of villi. These micronodules reacted variably for fibronectin. Some reacted strongly, in marked contrast with unreactive cells embedded within the nodules (Fig.  8) . Other apparently similar nodules reacted weakly or patchily, while some were largely or completely unreactive (Fig. 9) . None of such nodules stained uniformly in the way freshly formed fibrin does with the MSB (red) or PTAH (purple) stains. Nevertheless, nodules reactive with antifibronectin were also reactive for FRA. With van Gieson's fluid nodules showed a pale fuchsinophilia which contrasted with the intense red colour of the collagen of the core of the villi. With the picropolychrome stain the nodules could often be seen to be composed of fine blue-staining fibres which contrasted with the coarse red mature collagen fibres of the lamina propria. 
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Such appearances were considered to be consistent with an intermediate stage of organisation of nodular fibrin/fibronectin deposits (incorporated into the superficial lining of villi) and their replacement by freshly synthesised collagen but before the transformation of the latter into mature collagen. To study this further the immunoperoxidase technique was applied to the biopsies and also to selected specimens of rice bodies.
Distribution by immunoperoxidase technique. The application of this technique to the biopsy material available as frozen sections gave essentially the same picture for the codistribution of fibronectin and FRA as had been seen using immunofluorescence. But in those instances where material from the same patients was available fixed in cold ethanol or formalin the application of the immunoperoxidase technique provided better cytological detail and allowed additional observations. For example, occasionally in sections tangential to the surface of a villus the brown reaction product identifying the presence of the peroxidase-labelled antifibronectin antibody could be seen, not only on the cytoplasm of some synovial cells but also on cytoplasmic processes arising from such cells (Fig.  10) . This technique also confirmed the codistribution of fibronectin and FRA in the irregular extracellular masses in or on villi (Fig. 11) and allowed the direct observation of the negative reactions to these antisera of plasma cells and lymphoid cells in the lamina propria of villi.
The immunoperoxidase technique (applied as the PAP complex method) was also used to examine 'rice-bodies.' The loose granular debris so designated is heterogeneous detritus, consisting of fragments of synovium, cartilage, bone, and also of particles which are composed initially of fibrin but which, a with time, show varying degrees of organisation and conversion to fibrous tissue. For the present purpose specimens were selected from 12 patients known from a separate study6 to show various stages of this progression from fibrinous to fibrous rice body.
Immunohistological localisation of fibronectin and of FRA was contrasted with the results obtained with conventional histological staining methods.
Some rice bodies appeared to consist entirely of relatively freshly formed fibrin. These stained uniformly bright red with the MSB stain and purple with PTAH but failed to react for collagen in staining yellow with van Gieson's fluid and with the picropolychrome method. Rice bodies of this kind showed uniform and identical staining for fibronectin or FRA (Fig. 12) . Fig. 12 Rice bodies stained by MSB method. The irregularly shaped rice bodies in the upper portion of the field stained uniformly bright red in the original (as fibrin). The large rice body in the lower half of thefield stained red on its periphery but deep blue (as mature collagen) in the central portion. B: Correspondingfield in adjacent section from same block after treatment with rabbit antihuman fibrinogen and peroxidase-labelled sheep anti-rabbit IgG. Note uniform reactivity of upper rice bodies and ofperiphery of lower rice body but negative reaction of central area of latter. Identical distribution obtained with antifibronectin (see also Fig. 13 A, B, and C) Other rice bodies showed partial organisation and fibrosis. The process of fibrosis often seemed to begin in the core of the rice body which showed the staining reactions with van Gieson's fluid (deep pink), the MSB stain (blue), and picropolychrome (dark red) characteristic of mature collagen. The peripheral portions of such partially organised rice bodies showed variable reactions to these conventional stains. In some cases the outer layers of the rice body gave the staining reactions of fresh fibrin (as detailed above and see Fig. 12 In organised rice bodies in which elastic fibres and reticulin were demonstrable by conventional stains the distribution of fibronectin was not identical with that of elastin but was similar to that of reticulin ( Fig. 14 A and B) . A further study, with consecutive sections of similar material, is in progress to examine in more detail the relation between the distribution of fibronectin and reticulin.
Discussion
The experiments described above confirm that fibronectin is immunologically distinct from fibrinogen and establish that it is produced by synovial cells. This is not Fig. 14 A) . K 54. actually originate as the secretory product of fibroblasts and other connective tissue cells. If this is indeed the case, one would expect plasma levels to be affected only by very widespread and severe involvement of the connective tissue throughout the body.
In contrast the raised levels in synovial fluid from rheumatoid joints might possibly be accounted for by a restricted and localised increase in production of the protein actually at the site of the articular disease. Certainly the increased immunohistological localisation of fibronectin in the inflamed and hypertrophic synovium of arthritic, as opposed to control, joints would be consistent with this suggestion. In this sense the synovial fluid level of fibronectin may possibly serve as a better index of disease activity in a particular joint than more indirect tests, such as the erythrocyte sedimentation rate or the levels of acute phase proteins which are produced by the liver, and which presumably respond only to more generalised stimuli.
In normal human tissues Stenman and Vaheri27 have proposed a structural role for fibronectin in positioning and anchoring cells by securing the adhesion of cells to one another and to underlying substrata. This is because they found fibronectin to be distributed in health largely in the basement membranes underlying epithelial cells in many organs, as pericellular arrays, or as a loose meshwork in connective and areolar tissues. This, indeed, conforms in general with the distribution we have found of fibronectin in normal synovium. However, in inflamed membranes we observed fibronectin also to be codistributed with fibrin deposits. Initially this was seen as irregular masses of material on the surface of occasional villi. It has been suggested28 that this apparently specific adsorption of fibronectin on fibrin is due to the cross-linking of fibronectin to fibrin by the transglutaminase of plasma known as fibrin stabilising factor (factor XIII) during coagulation.
In Histologically defined 'reticulin' is known to contain certain noncollagenous glycoproteins,33 34 of which it is presumed27 that fibronectin is one. Isolated 'reticulin' from some tissues contains only type IV collagen, whereas that derived from immature tissues, such as embryonic skin or wound healing tissue, correlates with the distribution of type III collagen.
From these biochemical data and from the immunohistological distribution of fibronectin one might be led to expect that, if the latter reflects fibronectin distribution in the 'reticulins' of connective tissues, fibronectin would show in vitro preferential or selective affinity for type III (wound healing) or type TV (basement membrane) collagens. 35 However, in fact fibronectin has been shown to bind in vitro to the native, and perhaps even more strongly to the denatured, forms of all types of collagen. 3 7 24 36 The underlying biochemical basis of the above histological observations is thus not at present apparent.
Nevertheless, it is clear that fibronectin probably has an important structural and functional role in the organisation and repair of inflamed intraarticular structures. In our hands the distribution of fibronectin has been distinctive in actively involved rheumatoid joints as compared with most joints affected by osteoarthrosis. However, in longstanding arthritis showing evidence of intraarticular fibrosis, whether this was associated with RA or OA, certain broad similarities were seen in areas undergoing organisation. This is probably because it is now coming to be recognised that there are commonly inflammatory and healing components in long-standing OA. It has been suggested that fibronectin may also be concerned with the disposal of fibrin, collagen, and their degradation products by the reticuloendothelial system.37 38 It is therefore possible that the local production of fibronectin within affected joints may influence either the resolution or the continuance of arthritis, depending on the amounts synthesised by the stimulated synovial tissue. 
